With a Precision Dosing System (PDS) already helping thousands of patients with pain and spasticity, Infusyn is currently developing a breakthrough in the treatment of pulmonary arterial hypertension (PAH) that promises to significantly improve the lives of the estimated 50,000 patients suffering from the debilitating disease.

Learn more about Prometra, our advanced implantable

Our Partners